MedTrace Logo

IV Acetaminophen and Patent Ductus Arteriosus

NCT03008876 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2019-07-08

No results posted yet for this study

Summary

This is a randomized controlled trial to evaluate the efficacy of IV acetaminophen versus IV ibuprofen in closing a hemodynamically significant patent ductus arteriosus in preterm infants.

Conditions

  • Patent Ductus Arteriosus

Interventions

DRUG

Acetaminophen

infants receive acetaminophen for treatment of their PDA

DRUG

Ibuprofen

infants receive ibuprofen, standard of care in our unit, for treatment of a PDA

Sponsors & Collaborators

  • Albany Medical College

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Minute
Max Age
2 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03008876 on ClinicalTrials.gov